SABS: SAB Biotherapeutics Inc. Kompaniya qiymatining sof foydaga nisbati
SAB Biotherapeutics (SABS) uchun ushbu narx vizualizatsiyasi aktivning bazaviy baholashiga yordam beradi va -4.30 koeffitsiyentini namoyish etadi. Biznes qat'iy sterillik nazoratiga ega bo'lgan Janubiy Dakota shtatidagi zamonaviy biolaboratoriyalar va ixtisoslashtirilgan fermalarga tayanadi. Biroq, diabetga qarshi davolash vositalari uchun ishlab chiqarish tizimini kengaytirish ulkan investitsiyalarni talab qiladi, bu esa tashqi kapitalga qaramlikni yuzaga keltiradi. Antitanachlarning ishlab chiqilish murakkabligi kompaniyani biotexnologiya gigantlariga qarshi qo'yadi.
%20P%2FE%20multiplikatori&width=1200&height=400&colorIndex=0&v=mwczyyub.rjb-7czcsu8&start=20220704&end=20261112&filename=GURU_Markets_-_SABS_-_SAB-Biotherapeutics_-_PE-Multiple "SABS: SAB Biotherapeutics Biznesning o‘zini qoplash muddati 04.07.2022 - 12.11.2026 | 👁️GURU.Markets👁️")
SAB Biotherapeutics, Inc (SABS) kompaniyasining tahliliy kesimlari
- narx va narxlar bo'yicha konsensus prognoz:
- bozor kapitallashuvi haqida ma'lumot:
- buxgalteriya balansi bo'yicha sof aktivlar qiymati ko'rsatkichlari:
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Umumiy qarzning xususiy kapitalga nisbati SAB Biotherapeutics|SABS - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning kapitalga nisbati SAB Biotherapeutics Inc|SABS - Kompaniya qarzlari|Qarzning balans qiymatiga nisbati SAB Biotherapeutics, Inc.|SABS - Kompaniyaning uzoq muddatli qarzlari|Qisqa muddatli qarz SAB Biotherapeutics|Oraliq qoplama koeffitsiyenti sabbiotherapeutics.com
- foyda va bozor multiplikatorlari tafsilotlari:
SABS - Sof foyda|Prognoz qilingan kelajakdagi foyda SAB Biotherapeutics|SABS - P/E multiplikatori|Kelajakdagi narxning foydaga nisbati SAB Biotherapeutics Inc.|SABS - Narx-foyda va o‘sish multiplikatori|Biznes qiymatining amortizatsiya chegirilishidan oldingi operatsion foydaga nisbati SAB Biotherapeutics, Inc.|SABS - EBITDA operatsion foydasi|So'nggi o'n ikki oy davomida bir aksiya uchun foyda SAB Biotherapeutics|SABS - Bir aksiya uchun sof foyda (EPS TTM)|So'nggi o'n ikki oy davomida bir aksiya uchun sof foydaning yillik o'zgarishi sabbiotherapeutics.com|SABS - Joriy yilda bir aksiya uchun foyda o'sishi|Keyingi yilda bir aksiya uchun sof foydaning kutilayotgan o'sishi SAB Biotherapeutics
Kompaniyaning har tomonlama tahlili:sabbiotherapeutics.com SABS
P/E koeffitsiyenti foydaning bir birligining bozor qiymatini belgilaydi, bu esa investorga aktiv haddan tashqari qimmat baholanganmi yoki past baholanish potentsialiga egami ekanligini baholash imkonini beradi. SAB Biotherapeutics (SABS) kompaniyasining tarixiy P/E darajalarini tahlil qilish orqali, SAB Biotherapeutics (SABS) ning joriy baholashini uning diabet terapiyasi antitelalari rivojlanish sur'ati bilan solishtirish va bozor platformaning III fazaga muvaffaqiyatli o'tishini hozirda qanchalik darajada narxlayotganini baholash mumkin.
Muhim raqobatchilar
P/E multiplikatori argenx.com|Narx-foyda koeffitsiyenti BNTX (BioNTech)|ABVX (ABIVAX) - Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori ADMA (ADMA Bio)|Biznesning o‘zini qoplash muddati Protagonist Corp (PTGX)|IMVT - Narxning foydaga nisbati|kiniksa.com (KNSA) - Narx-foyda koeffitsiyenti|Grifols (GRFS) - Narxning foydaga nisbati|Narx-foyda koeffitsiyenti Adaptive Biotech|Narx-foyda koeffitsiyenti CLDX|P/E multiplikatori Aurinia Corp|Narxning foydaga nisbati BioCryst (BCRX)|veratx.com - Narx-foyda multiplikatori|P/E multiplikatori DNTH (Dianthus Therapeutics, Inc.)|Pharvaris NV (PHVS) - Kapitalizatsiyaning foydaga nisbati|ABCL - Narxning foydaga nisbati|Biznesning o‘zini qoplash muddati Tourmaline TRML|PGEN: P/E multiplikatori|pharming.com (PHAR) - P/E multiplikatori|NKTR (Nektar Therapeutics Inc.) - P/E multiplikatori|Narxning foydaga nisbati UPB|Narx-foyda koeffitsiyenti ZBIO (Zenas Biopharma, Inc.)|IMNM (Immunome Bio) - Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori GOSS (Gossamer Bio, Inc.)|kalvista.com - Narxning foydaga nisbati|Septerna - P/E multiplikatori|Biznesning o‘zini qoplash muddati Pieris Pharma PVLA|Savara Corp (SVRA) - Narxning foydaga nisbati|Kapitalizatsiyaning foydaga nisbati Rigel Corp (RIGL)|Narx-foyda koeffitsiyenti ANAB|ATXS (astriatx.com) - Bozor narxining sof foydaga nisbati|P/E multiplikatori ENGN|RAPT (RAPT Therapeutics Inc.) - Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori JBIO (Aerovate Therapeutics)|Aclaris Therapeutics, Inc (ACRS) - Kapitalizatsiyaning foydaga nisbati|KYTX - Narxning foydaga nisbati|Kompaniya qiymatining sof foydaga nisbati TLSA (tizianalifesciences.com)|CABA: P/E multiplikatori|Ventyx Biosciences Inc. (VTYX) - P/E multiplikatori|Narxning foydaga nisbati Theratechnologies Inc|Avalo Therapeutics Inc - Kapitalizatsiyaning sof foydaga nisbati|P/E multiplikatori ELDN|AGEN - Kapitalizatsiyaning foydaga nisbati|Climb Bio - Narx-foyda koeffitsiyenti|P/E multiplikatori Zura Bio Ltd ZURA|ATYR: Narx-foyda koeffitsiyenti|Adagene - Bozor narxining sof foydaga nisbati|IMA: P/E multiplikatori|STTK - Biznesning o‘zini qoplash muddati|EQ (Equillium Inc) - P/E multiplikatori|Narx-foyda koeffitsiyenti Connect Pharma (CNTB)|Narxning foydaga nisbati Immunic, Inc. (IMUX)|Biznesning o‘zini qoplash muddati atarabio.com|Narxning foydaga nisbati InflaRx IFRX|Biznesning o‘zini qoplash muddati x4pharma.com (XFOR)|Adicet - P/E multiplikatori|CELU - P/E multiplikatori|INMB: P/E multiplikatori|BRNS (Barinthus Biotherapeutics Corp) - Narxning foydaga nisbati|Narxning foydaga nisbati Kezar Life Sciences|akaritx.com (AKTX) - Biznesning o‘zini qoplash muddati|Narxning foydaga nisbati Enlivex Therapeutics (ENLV)|QTTB: Kapitalizatsiyaning sof foydaga nisbati|P/E multiplikatori GOVX (GeoVax Labs Inc)|Kompaniya qiymatining sof foydaga nisbati EDSA|iBio, Inc. - P/E multiplikatori|CARM - P/E multiplikatori|XTL Biopharmaceuticals Ltd. (XTLB) - Narxning foydaga nisbati|Bolt Biotherapeutics, Inc. - Kompaniya qiymatining sof foydaga nisbati|Narxning foydaga nisbati HCW Biologics, Inc.|Narx-foyda koeffitsiyenti Aptevo (APVO)|P/E multiplikatori AIM|P/E multiplikatori aditxt.com (ADTX)|GRI Bio - Narx-foyda koeffitsiyenti|Kompaniya qiymatining sof foydaga nisbati XRTX|ReShape Lifesciences - P/E multiplikatori|Biznesning o‘zini qoplash muddati Revelation Biosciences Corp REVB|Indaptus Therapeutics (INDP) - Narxning foydaga nisbati|Narx-foyda koeffitsiyenti scinai.com|Narxning foydaga nisbati CalciMedica Inc|Narx-foyda koeffitsiyenti Affimed Therapeutics (AFMD)|Narx-foyda koeffitsiyenti ALLK (Allakos Inc.)|P/E multiplikatori hookipapharma.com (HOOK)|Narxning foydaga nisbati IGM Biosciences IGMS|ITOS: Narx-foyda multiplikatori|Ocean Biomedical - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati TC BioPharm (Holdings) Plc|Third Harmonic Bio, Inc (THRD) - Narxning foydaga nisbati
